FMP
West Pharmaceutical Services, Inc.
WST
NYSE
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
213.06 USD
-1.68 (-0.789%)
Mr. Eric M. Green
Healthcare
Medical - Instruments & Supplies
NYSE
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection a...
0000105770
US9553061055
955306105
530 Herman O. West Drive
610 594 2900
US
10,600
Mar 17, 1980
0000105770
NYSE
Medical - Instrument...
Healthcare
955306105
US9553061055
US
213.06
1.14
1.21M
15.31B
-
187.43-372.52
123.47
-
-
-
-
33.45
-
https://www.westpharma.com
We are unable to load the data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Alex Lavoie
Apr 23, 2025
West Pharmaceutical Services, Inc. (NYSE:WST) is a key player in the pharmaceutical industry, specializing in the design and manufacture of innovative solutions for injectable drug administration. The company is known for its strong presence in the biologics and contract manufacturing sectors. As WST prepares to release its first-quarter 2025 earnings, investors are keenly watching the anticipated figures. Wall Street estimates WST's earnings per share (EPS) to be $1.22, with projected revenue ...
Stuart Mooney
Feb 13, 2025
West Pharmaceutical Services, Inc. (NYSE:WST) is a key player in the medical and dental supplies industry. The company specializes in the design and manufacture of innovative solutions for injectable drug administration. WST competes with other industry giants, focusing on providing high-quality products that meet the needs of healthcare providers and patients worldwide. On February 13, 2025, WST reported earnings per share (EPS) of $1.82, surpassing the estimated $1.71. This performance also e...
Rayan Ahmad
Feb 13, 2025
Casella Waste Systems, Inc. (NASDAQ:CWST) is a company that provides waste management services, including collection, transfer, disposal, and recycling. It operates primarily in the northeastern United States. The company competes with other waste management firms like Waste Connections, Inc., Clean Harbors, Inc., and Republic Services, Inc. These companies are also involved in similar waste management and environmental services. In analyzing Casella's financial performance, the Return on Inves...
Parth Sanghvi
Aug 6, 2024
Twist Bioscience Reports Robust Q3 Growth and Targets Higher Margins: Key Insights from the Earnings Call Twist Bioscience has recently shared its Q3 earnings report, highlighting impressive growth and ambitious plans for increasing profit margins. The company’s earnings call provided valuable details on its performance, strategic goals, and future outlook. Here’s a comprehensive overview of Twist Bioscience’s recent achievements and strategic focus. Highlights from Twist Bioscience’s Q3 E...
Seeking Alpha
Jul 25, 2024
West Pharmaceutical Q2'24 results missed expectations, with lower revenues and EPS missing guidance, impacted by destocking and poor sales in various segments. Management remains optimistic for the back half of the year, with capital investments to support growth, but cash flow concerns and high valuation pose risks. Despite the recent drop in WST share price, the company's high valuation and uncertain cash flow outlook make it unattractive for investment at this time.
Zacks Investment Research
Jul 25, 2024
West Pharmaceutical's (WST) second-quarter results reflect a declining demand for products across its segments amid elevated customer destocking.
Zacks Investment Research
Jul 25, 2024
West Pharmaceutical Services (WST) came out with quarterly earnings of $1.52 per share, missing the Zacks Consensus Estimate of $1.77 per share. This compares to earnings of $2.11 per share a year ago.
Reuters
Jul 25, 2024
West Pharmaceutical Services cut its annual profit and sales forecast on Thursday, on lower demand for its medical equipment used in making injectable drugs as biotech customers worked through their existing inventories.